Qemiq Pharma Private Limited
About Qemiq Pharma Private Limited
Data last updated:
Qemiq Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 20 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U43309TG2020PTC141937. Its GSTIN is 36AATCA7176P1ZM (Telangana).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6 Cr. It was formerly known as Arr Capital Investment Private Limited. It is led by directors Nikhil Reddy Pasya and Niranjan Dasari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 – 7 – 64/A1/1 Saraswathi Block Triveni Complex, Hyderabad, Telangana, India – 500013.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a growth of 150% compared to the previous year. For the same year it recorded a net profit of ₹1.48 Cr (net margin 70.8%) and EBITDA of ₹1.73 Cr (EBITDA margin 82.8%).
Company details
CIN history
Qemiq Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U43309TG2020PTC141937, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U43309TG2020PTC141937 | Current |
| U24100TG2020PTC141937 | Previous |
| U67100TG2020PTC141937 | Previous |
Contact details
Qemiq Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address4 – 7 – 64/A1/1 Saraswathi Block Triveni Complex, Hyderabad, Telangana, India – 500013
- IndustryFinancial Services, Diversified Financial Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Qemiq Pharma is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Qemiq Pharma Private Limited, buy the company report.
Financials of Qemiq Pharma Private Limited
FY 2025 filings availableQemiq Pharma Private Limited reported revenue of ₹2.1 Cr (up 150% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.73 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 82.8% | ||||
| Net Profit Margin | 70.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Qemiq Pharma Private Limited, buy the company report.
Board of directors of Qemiq Pharma Private Limited
Qemiq Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Reddy Pasya | Director | 20 Jul 2020 | 6 Years 3 Months | Current |
| Niranjan Dasari | Director | 20 Jul 2020 | 6 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Qemiq Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qemiq Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Qemiq Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCA7176P1ZM | Telangana | Active | 11 Dec 2020 |
To see the full GST registrations and return filing status of Qemiq Pharma Private Limited, buy the company report.
Recent activity
Qemiq Pharma Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Pushpalatha Vustala ceased to be Director on 09 Sep 2024.
Frequently asked questions
Qemiq Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 20 July 2020 (6+ years old) and is registered under CIN U43309TG2020PTC141937.
Qemiq Pharma has 2 current directors:
- Nikhil Reddy Pasya - Director
- Niranjan Dasari - Director
The latest financial statements of Qemiq Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Qemiq Pharma is 36AATCA7176P1ZM, registered in Telangana.
The CIN (Corporate Identification Number) of Qemiq Pharma is U43309TG2020PTC141937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qemiq Pharma was incorporated on 20 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pushpalatha Vustala ceased to be Director on 09 Sep 2024. Rajasekhar Reddy Puchakayala ceased to be Director on 18 Jan 2023. Sravani Reddy Gantla ceased to be Director on 18 Jan 2023. Qemiq Pharma has 5 board changes on record in total.
The registered office of Qemiq Pharma is at 4 – 7 – 64A11 Saraswathi Block Triveni Complex, Hyderabad, Telangana, India – 500013.
Qemiq Pharma operates in the financial services industry, in the diversified financial services segment.
Yes. Qemiq Pharma was formerly known as Arr Capital Investment Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
